ImClone to make a payment of $65 M to Repligen and the MIT

11.09.2007

Repligen Corporation has reached a settlement with ImClone Systems Inc. in the lawsuit against ImClone for infringement of US Patent No. 4,663,281 based on ImClone's manufacture and sale of Erbitux.

Oracle and Sophoi Certify Sophoi IP-Licensing Suite with Oracle Fusion Middleware

10.09.2007

Sophoi launched a new Intellectual Property Licensing Suite (iPLS 3.0) - an enterprise-scale business solution for Intellectual Property (IP) management and licensing.

Request for Comment on the Future of the Madrid Protocol - IP Australia

10.09.2007

IP Australia is seeking comment from trademark owners in the context of ongoing international consideration of the future development of the Madrid system.

Affymetrix and Empire Genomics Enter Into Licensing Agreement

09.09.2007

Empire Genomics LLC has obtained a non-exclusive, worldwide license to a number of Affymetrix patents covering the manufacturing, use and sale of nucleic acid microarrays and related products and services for comparative genomic hybridization (CGH). The arrays and services may be used for research or diagnostic purposes. Financial details of the license were not disclosed.

APEC Economic Leaders’ Meeting Concludes, Calls for More IPRs Protection

09.09.2007

Leaders of the Fifteenth Asia-Pacific Economic Cooperation (APEC) concluded their meeting in Australia, September 8-9, 2007, with calls for strengthening and enforcing of Intellectual Property Rights (IPRs).

Novartis to Defend Its IPRs for Famvir Despite an "At-Risk" Generic Launch in the US

09.09.2007

Novartis plans to keep defending its IPRs for the antiviral medicine Famvir, which has various US patents valid until 2015, after a competitor company, Teva Pharmaceuticals, launched its own generic version in the United States.